Pcyc-1141-Ca
ClinicalTrials.gov NCT02947347
Research payments
$1,092,724
Through program year 2020, $1,092,724 in research payments was reported against Pcyc-1141-Ca, across 429 payments, paid by Pharmacyclics LLC, An AbbVie Company.
- Paid by
- Pharmacyclics LLC, An AbbVie Company
- ClinicalTrials.gov
- NCT02947347
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $1,092,724 | 429 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Daniel Greenwald Santa Barbara, CA Named on 69 payments
- Habte Yimer Tyler, TX Named on 51 payments
- Jerome Goldschmidt Wytheville, VA Named on 48 payments
- Michael Meshad Daphne, AL Named on 42 payments
- Suzanne Fanning Greenville, SC Named on 28 payments
- Don Stevens Louisville, KY Named on 16 payments
- Ian Flinn Brentwood, TN Named on 14 payments
- Gary Takahashi Beaverton, OR Named on 12 payments
- Kristi McIntyre Dallas, TX Named on 9 payments
- Ketan Doshi Ocala, FL Named on 9 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.